These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Botulinum toxins in the treatment of primary focal dystonias. Truong D J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699 [TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. Karp BI; Alter K Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500 [TBL] [Abstract][Full Text] [Related]
8. Peripheral trauma and risk of dystonia: What are the evidences and potential co-risk factors from a population insurance database? Macerollo A; Edwards MJ; Huang HC; Lu MK; Chen HJ; Tsai CH; Chen JC PLoS One; 2019; 14(5):e0216772. PubMed ID: 31075156 [TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials. Del Sorbo F; Albanese A Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of focal dystonia with botulinum toxin A]. Sojer M; Wissel J; Müller J; Poewe W Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045 [TBL] [Abstract][Full Text] [Related]